Division of Genetics and Genomics and Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics and Neurology, Harvard Medical School, Boston, MA, USA.
Division of Genetics and Genomics and Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics and Neurology, Harvard Medical School, Boston, MA, USA.
Neuron. 2020 Apr 22;106(2):246-255.e6. doi: 10.1016/j.neuron.2020.01.030. Epub 2020 Feb 24.
Genes mutated in human neuronal migration disorders encode tubulin proteins and a variety of tubulin-binding and -regulating proteins, but it is very poorly understood how these proteins function together to coordinate migration. Additionally, the way in which regional differences in neocortical migration are controlled is completely unknown. Here we describe a new syndrome with remarkably region-specific effects on neuronal migration in the posterior cortex, reflecting de novo variants in CEP85L. We show that CEP85L is required cell autonomously in vivo and in vitro for migration, that it localizes to the maternal centriole, and that it forms a complex with many other proteins required for migration, including CDK5, LIS1, NDE1, KIF2A, and DYNC1H1. Loss of CEP85L disrupts CDK5 localization and activation, leading to centrosome disorganization and disrupted microtubule cytoskeleton organization. Together, our findings suggest that CEP85L highlights a complex that controls CDK5 activity to promote neuronal migration.
在人类神经元迁移障碍中发生突变的基因编码微管蛋白和各种微管结合和调节蛋白,但这些蛋白如何协同作用来协调迁移仍知之甚少。此外,新皮质迁移的区域差异是如何被控制的完全未知。在这里,我们描述了一种新的综合征,该综合征对后部皮层的神经元迁移具有显著的区域特异性影响,反映了 CEP85L 的从头变体。我们表明,CEP85L 在体内和体外迁移中都需要细胞自主性,它定位于母中心粒,并且与许多其他迁移所需的蛋白质形成复合物,包括 CDK5、LIS1、NDE1、KIF2A 和 DYNC1H1。CEP85L 的缺失会破坏 CDK5 的定位和激活,导致中心体紊乱和微管细胞骨架组织的破坏。总之,我们的研究结果表明,CEP85L 突出了一个控制 CDK5 活性以促进神经元迁移的复合物。